Biomerica Appoints Scott Madel as Chief Commercial Officer to Boost Growth and Revenue

Biomerica Inc. has appointed Scott Madel as its Chief Commercial Officer, bringing over 20 years of experience in revenue growth leadership in laboratory testing, clinical diagnostics, and global expansion. Madel has a track record of commercializing advanced laboratory testing, driving growth and payer strategies, and has successfully led organizational turnarounds and growth strategies at Boston Heart Diagnostics and Genova Diagnostics. He will focus on expanding and accelerating commercialization and revenue growth for Biomerica's inFoods IBS diagnostic-guided therapy.